AKT1 and breast cancer: Fasting/FMD and ET in breast cancer cells were shown to cooperate to reduce the Akt-mediated inhibition of tumor suppressor EGR1 (a well-established enhancer of PTEN expression), thereby increasing PTEN levels and reinforcing Akt inhibition.